Bufuralol 1'-hydroxylase activity of the rat

This publication has 20 references indexed in Scilit:

• Phenacetin O‐deethylase: an activity of a cytochrome P‐450 showing genetic linkage with that catalysing the 4‐hydroxylation of debrisoquine?
  British Journal of Clinical Pharmacology, 1985
• Debrisoquine-type polymorphism of drug oxidation: purification from human liver of a cytochrome P450 isozyme with high activity for bufuralol hydroxylation
  FEBS Letters, 1984
• Polymorphic ability to metabolize propranolol alters 4-hydroxypropranolol levels but not beta blockade
  Clinical Pharmacology & Therapeutics, 1984
• Purification and characterization of the rat liver microsomal cytochrome P-450 involved in the 4-hydroxylation of debrisoquine, a prototype for genetic variation in oxidative drug metabolism
  Biochemistry, 1984
• Polymorphic oxidation of sparteine and debrisoquine: Related pharmacogenetic entities
  Clinical Pharmacology & Therapeutics, 1982
• The genetic controlof bufuralol metabolisminman
  European Journal of Drug Metabolism and Pharmacokinetics, 1982
• Defective Oxidation of Drugs
  Clinical Pharmacokinetics, 1982
• Animal modelling of human polymorphic drug oxidation—the metabolism of debrisoquine and phenacetin in rat inbred strains
  Journal of Pharmacy and Pharmacology, 1981
• Evidence for an enzymatic defect in the 4-hydroxylation of debrisoquine by human liver.
  Published by Wiley ,1981
• POLYMORPHIC HYDROXYLATION OF DEBRISOQUINE IN MAN
  The Lancet, 1977